Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Vaccinations01:51

Vaccinations

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seeking universal malaria-vaccine targets.

Nature·2026
Same author

Transcriptional profiling of the Crocodylus porosus liver cell response to Kunjin virus reveal novel insights into the host-virus interface.

Microbial pathogenesis·2026
Same author

A novel hookworm vaccine candidate identified through immunomic profiling of human protective immunity.

International journal for parasitology·2026
Same author

Transgenic hookworm secretes anti-tetrodotoxin human single chain antibody.

Nature communications·2026
Same author

Advances in vaccine development through the controlled human infection models for hookworm and schistosomiasis.

PLoS neglected tropical diseases·2026
Same author

Optimized hookworm-derived biologic, AIP-2<sub>NTQ48</sub> restores mucosal tolerance and down-regulates colon cancer-associated gene expression in TNBS-induced colitis.

Mucosal immunology·2026
Same journal

Evaluation of the diagnostic performance of a commercial ELISA based on two recombinant antigens for the diagnosis of Strongyloides stercoralis infection.

Parasites & vectors·2026
Same journal

Trouble from the tiger: first detection of dengue virus in Aedes albopictus in Australia during a 2024 dengue outbreak on Masig Island.

Parasites & vectors·2026
Same journal

Mitochondrial COI and 16S rDNA barcoding improve species delimitation of ixodid ticks in Peninsular Malaysia.

Parasites & vectors·2026
Same journal

Immune-reproductive cross talk in mosquitoes: molecular pathways and energy homeostasis.

Parasites & vectors·2026
Same journal

A novel activation-related gene P158 is essential for evagination and early development of Echinococcus multilocularis protoscoleces.

Parasites & vectors·2026
Same journal

Seroprevalence of Dirofilaria immitis in traveling dogs: implications for transboundary pathogen movement.

Parasites & vectors·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2026

Using Eggs from Schistosoma mansoni as an In vivo Model of Helminth-induced Lung Inflammation
09:58

Using Eggs from Schistosoma mansoni as an In vivo Model of Helminth-induced Lung Inflammation

Published on: June 5, 2012

Schistosomiasis vaccine discovery using immunomics.

Patrick Driguez1, Denise L Doolan, Alex Loukas

  • 1Molecular Parasitology Laboratory, The Queensland Institute of Medical Institute, Herston, Queensland 4006, Australia. patrick.driguez@qimr.edu.au.

Parasites & Vectors
|February 26, 2010
PubMed
Summary
This summary is machine-generated.

Researchers developed a Schistosoma immunomics protein microarray for vaccine discovery. This tool utilizes genomic data to identify potential schistosome vaccine candidates, advancing parasitic disease research.

More Related Videos

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
08:46

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

Zika Virus Specific Diagnostic Epitope Discovery
11:37

Zika Virus Specific Diagnostic Epitope Discovery

Published on: December 12, 2017

Related Experiment Videos

Last Updated: Jun 15, 2026

Using Eggs from Schistosoma mansoni as an In vivo Model of Helminth-induced Lung Inflammation
09:58

Using Eggs from Schistosoma mansoni as an In vivo Model of Helminth-induced Lung Inflammation

Published on: June 5, 2012

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
08:46

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

Zika Virus Specific Diagnostic Epitope Discovery
11:37

Zika Virus Specific Diagnostic Epitope Discovery

Published on: December 12, 2017

Area of Science:

  • Parasitology
  • Immunology
  • Genomics

Background:

  • Genome sequencing of Schistosoma japonicum and S. mansoni provides new avenues for schistosomiasis vaccine development.
  • Immunomics protein microarrays have proven effective for vaccine antigen discovery in various infectious agents.

Purpose of the Study:

  • To design and create a Schistosoma immunomics protein microarray for identifying novel vaccine candidates.
  • To leverage post-genomic information for schistosomiasis vaccine research.

Main Methods:

  • Selection of potential immunogens based on published data, in silico screening (location, homology, specificity), and available schistosome sequences.
  • Cell-free expression of selected sequences and printing onto nitrocellulose microarrays.
  • Detection of protein reactivity using patient/animal antisera and a laser scanner.

Main Results:

  • A Schistosoma immunomics protein microarray was successfully manufactured as a vaccine discovery tool.
  • The microarray platform allows for the assessment of protein reactivity against schistosome-exposed sera.
  • Highly reactive proteins identified can be further evaluated as potential vaccine candidates.

Conclusions:

  • Immunomics protein microarrays represent an innovative approach for schistosomiasis vaccine discovery.
  • This technology has the potential to significantly advance vaccine research for schistosomiasis and other parasitic diseases.
  • The integration of genomic data with microarray technology accelerates the identification of protective antigens.